TQB3142

TQB3142 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3142, covering 2026-01-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors [Phase 1]

See pricing